FIGO Staging for Ovarian Cancer (2014)
Stages cancer of the ovary, fallopian tube, and peritoneum.
Hematology and Oncology
114 entries · Page 2 of 4
F
Fleischner Society Guidelines for Incidental Pulmonary Nodules
Provides guidelines for management of solid and subsolid pulmonary nodules.
Follicular Lymphoma International Prognostic Index (FLIPI)
Estimates overall survival based on clinical information.
Fong Clinical Risk Score for Colorectal Cancer Recurrence
Predicts recurrence for colorectal cancer patients with liver metastasis after hepatic resection.
Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma
Provides prognostic grading system for tumor cells based on physical cellular appearance.
G
Gail Model for Breast Cancer Risk
Estimates risk for breast cancer based on demographic and clinical data.
GALAD Model for Hepatocellular Carcinoma (HCC)
Diagnoses HCC based on serum biomarkers in patients with chronic liver disease (CLD).
Ganzoni Equation for Iron Deficiency Anemia
Assesses total body iron deficit for iron replacement therapy.
Geneva Score (Revised) for Pulmonary Embolism
Objectifies risk of PE, like Wells' score.
Glasgow Prognostic Score (GPS) for Cancer Outcomes
Provides cancer prognosis based on serum biomarkers.
Glasgow-Blatchford Bleeding Score (GBS)
Stratifies upper GI bleeding patients who are "low-risk" and candidates for outpatient management.
Gleason Score for Prostate Cancer
Prognoses prostate cancer based on microscopic tumor appearance.
Groupe d'Etude des Lymphomes Folliculaires (GELF) Criteria
Determines if immediate therapy for follicular lymphoma is required.
H
HAS-BLED Score for Major Bleeding Risk
Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.
HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage
Assesses hemorrhage risk after tPA.
Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI)
Predicts survival after HCT in patients with hematologic malignancies, including optional age adjustment.
HEMORR₂HAGES Score for Major Bleeding Risk
Quantifies risk of hemorrhage in elderly patients with AFib.
HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTE
Identifies low-risk women who can safely discontinue VTE treatment.
Hestia Criteria for Outpatient Pulmonary Embolism Treatment
Identifies low-risk PE patients safe for outpatient treatment.
HIT Expert Probability (HEP) Score for Heparin-Induced Thrombocytopenia
Pre-test clinical scoring model for HIT based on broad expert opinion.
Hour-Specific Risk for Neonatal Hyperbilirubinemia
Predicts risk of hyperbilirubinemia in neonates.
HScore for Reactive Hemophagocytic Syndrome
Diagnoses reactive hemophagocytic syndrome.
I
IMDC (International Metastatic RCC Database Consortium) Risk Model for Metastatic Renal Cell Carcinoma
Predicts survival in patients with metastatic renal cell carcinoma treated with systemic therapy (also known as Heng criteria).
Immune-Related Adverse Events for GI Toxicity - Colitis
Grades severity of colitis secondary to immune checkpoint inhibitor therapy.
International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI)
Stratifies patients with chronic lymphocytic leukemia into four risk categories.
International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI)
Predicts overall and progression-free survival in DLBCL based on risk factors.
Intrauterine RBC Transfusion Dosage
Estimates volume of donor RBCs needed for intrauterine transfusion (IUT).
ISTH Criteria for Disseminated Intravascular Coagulation (DIC)
Diagnoses overt disseminated intravascular coagulation (DIC).
K
Karnofsky Performance Status Scale
Determines ability of patient to tolerate chemotherapy.
Khorana Risk Score for Venous Thromboembolism in Cancer Patients
Predicts risk of VTE for cancer patients depending on type of cancer and other factors.
No entries match your filter.